A collaboration to make retinal imaging more accessible and cost-effective.
Ainnova Tech partnered with ITEK to develop an AI-powered, affordable imaging device for early disease detection.
The collaboration reflects Ainnova's commitment to revolutionizing how retinal images are captured — making screening more accessible and cost-effective.
By combining Ainnova's VisionAI software with purpose-built imaging hardware, the collaboration aimed to lower the cost and complexity of retinal screening.
Making retinal image capture more affordable is central to Ainnova's mission of accessible early detection.
Ainnova Tech is a healthcare technology company focused on revolutionizing early disease detection using artificial intelligence. Its platform, VisionAI, analyzes retinal images to detect early markers of diseases such as diabetic retinopathy — with a growing portfolio spanning cardiovascular, metabolic, liver and kidney risk. Ainnova is dedicated to making healthcare more proactive, accessible and efficient.
Source: Read on ITEK ↗
Contact: Ainnova Tech — info@ainnovatech.com